2004
DOI: 10.1007/s00439-004-1199-2
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial GTPase mitofusin 2 mutation in Charcot?Marie?Tooth neuropathy type 2A

Abstract: Charcot-Marie-Tooth disease (CMT) has been classified into two types, CMT1 and CMT2, demyelinating and axonal forms, respectively. CMT2 has been further subdivided into eight groups by linkage studies. CMT2A is linked to chromosome 1p35-p36 and mutation in the kinesin family member 1B-beta (KIF1B) gene had been reported in one pedigree. However, no mutation in KIF1B was detected in other pedigrees with CMT2A and the mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) gene were recently detected in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

11
173
1
1

Year Published

2006
2006
2014
2014

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 230 publications
(186 citation statements)
references
References 17 publications
11
173
1
1
Order By: Relevance
“…This raises the question of whether, in addition to regulating the mitochondrial fusion/fission process, these dynamically related proteins also play a role in mediating autophagic processes in the heart. MFN2 was originally identified as a mitochondrial protein mediating fusion of the mitochondrial outer membrane, and mutation of MFN2 is causally associated with Charcot-MarieTooth type 2A, a neurodegenerative disease (17,18). In addition to mediating mitochondrial fusion, MFN2 localizes on the ER membrane, serving as a bridge to tether the ER to mitochondria (19).…”
mentioning
confidence: 99%
“…This raises the question of whether, in addition to regulating the mitochondrial fusion/fission process, these dynamically related proteins also play a role in mediating autophagic processes in the heart. MFN2 was originally identified as a mitochondrial protein mediating fusion of the mitochondrial outer membrane, and mutation of MFN2 is causally associated with Charcot-MarieTooth type 2A, a neurodegenerative disease (17,18). In addition to mediating mitochondrial fusion, MFN2 localizes on the ER membrane, serving as a bridge to tether the ER to mitochondria (19).…”
mentioning
confidence: 99%
“…Notably, mutations in genes controlling mitochondrial fusion have been directly associated with several human diseases. Mutations in Mfn2 were found in patients with Charcot-Marie-Tooth neuropathy type 2A (27,28), and mutations in the OPA1 gene have been shown to cause dominant optic atrophy (29,30). Thus, defects in mitochondrial fusion cause cellular dysfunctions that relate to different human diseases.…”
mentioning
confidence: 99%
“…Fragmentation leads to a loss of mtDNA and respiratory incompetence in yeast (1,2) and accumulation of poorly functional mitochondria in mammals (3). Mice deficient for mitochondrial fusion die during mid gestation (4), and mutations in the mitochondrial fusion genes Mfn2 and OPA1 cause the neurodegenerative diseases Charcot-Marie-Tooth disease type 2A and dominant optic atrophy, respectively (5)(6)(7)(8)(9). Importantly, the mitochondrial fusion machinery is dedicated solely to mitochondrial fusion and does not include SNARE 2 proteins or NSF (N-ethylmaleimide-sensitive protein), which mediate most other intracellular membrane fusion events.…”
mentioning
confidence: 99%